Use of a VEGF antagonist to treat angiogenic eye disorders

• 收藏
• 分享

专利权人:

Inc.;Regeneron Pharmaceuticals

发明人:

Yancopoulos, George D.

申请号：

AU2012205599

公开号：

AU2012205599A1

申请日:

2012.01.11

申请国别(地区):

AU

年份:

2013

代理人:

摘要：

The present invention provides methods for treating angiogenic eye disorders by sequentially administering multiple doses of a VEGF antagonist to a patient. The methods of the present invention include the administration of multiple doses of a VEGF antagonist to a patient at a frequency of once every 8 or more weeks. The methods of the present invention are useful for the treatment of angiogenic eye disorders such as age related macular degeneration, diabetic retinopathy, diabetic macular edema, central retinal vein occlusion and corneal neovascularization.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/